Bringing the fundamentals into focus…
Back to Royalty Pharma plc
How Royalty Pharma plc stacks up
RPRX · against 1,336 other Healthcare companies
Valuation
50/ 100
Below the middle of the pack.
Ranked #663 of 1,337 · scores higher than 50% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 50–59, including RPRX · Click a bar to see the companies
Why valuation scores 50?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- EBITDA yield is close to the peer norm. EBITDA yield: 3.3% vs peer median 4.0%
- Earnings yield is close to the peer norm. Earnings yield: 2.2% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 90% of peers. Free cash flow yield: 7.8% vs peer median 0.0%
Metric by metric
Position: dot = RPRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RPRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 2.8% | 1.5% | 60% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 3.7% | 4.2% | 48% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 7.8% | -1.0% | 90% | 20% | |
| Book yieldHigher is better · 1,306 reported | 23.1% | 37.9% | 32% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around RPRX| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 663 | 36.0B USD | 50 | 46 | |
| 663 | 9.0B USD | 50 | 78 | |
| 663 | 6.3B USD | 50 | 78 | |
| 663 | 126.5B USD | 50 | 56 | |
| 663 | 38.4B USD | 50 | 50 | |
| 663 | 304M EUR (≈$334M) | 50 | 42 | |
| 676 | 11.0B CNY (≈$1.5B) | 49 | 57 | |
| 676 | 3.0B CNY (≈$427M) | 49 | 36 | |
| 676 | 2.3B CNY (≈$318M) | 49 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score